This is the authors' abstract. We don't add key points for this paper.
Human β-defensin 3 (HBD3), is an anti-microbial host-defence peptide, that can rapidly enter macrophages to modulate TLR4 responses to lipopolysaccharide. However, the molecular mechanisms by which HBD3 exerts this anti-inflammatory influence remain unclear. Here, we show mice deleted for the orthologue of HBD3 have an increased acute lipopolysaccharide response in vivo . Furthermore, we found that HBD3 limited the response of macrophages to classical activation, and contemporaneously drove expression of IL-4. An increase in markers of alternative activation, and a change in metabolic flux was also observed. Consistent with these results, HBD3 enhanced the IL-4 mediated polarisation of naïve macrophages. Finally, we demonstrate that the ability of HBD3 to limit macrophage classical activation requires IL-4Rα. These data reveal a previously unrecognised role for HBD3 in influencing the polarisation state of macrophages to enable a state conducive for repair and resolution. SYNOPSIS The anti-microbial host-defence peptide, Human β-defensin 3 (HBD3), is shown here to modulate the inflammatory response to classical activation by promoting alternative activation through IL-4Rα, to enable a state conducive for repair and resolution. Knockout mice for the orthologous gene for HBD3, demonstrate increased acute lipopolysaccharide inflammatory response. HBD3 limited the classical activation of macrophages polarised with LPS/IFNγ and drove expression of IL-4. Cells also displayed increase in alternative activation markers and promotion of oxidative phosphorylation. HBD3 enhanced the IL-4-mediated activation of naïve macrophages. The ability of HBD3 to limit macrophage classical activation and contemporaneously promote alternative activation required IL-4Rα.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Candela et al. (2021) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: